Europe Retail Pharmacy Market By Type of Pharmacy (Chain Pharmacies, Independent Pharmacies, Hospital Pharmacies, Mail Order Pharmacies, Online Pharmacies); By Type of Prescription (Prescription Drugs [Rx], Over-the-Counter [OTC] Drugs); By Service Offered (Medication Dispensing, Health Screenings, Vaccination Services, Consultation and Counseling, Chronic Disease Management); By Product Type (Generic Drugs, Branded Drugs); By Application (Oncology, Diabetes, Neurology, Others); By Customer (Paediatric, Adults, Geriatric) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
The Europe Retail Pharmacy Market was valued at USD 227.68 billion in 2018 and reached USD 316.70 billion in 2025, reflecting steady expansion supported by rising prescription volumes, wider access to over-the-counter medicines and stronger demand for pharmacy-led healthcare services. The market is projected to reach USD 396.17 billion by 2032, growing at a CAGR of 3.19% from 2025 to 2032.
Growth is driven by aging demographics, increasing chronic disease prevalence, digital pharmacy adoption and expanding consumer reliance on retail pharmacies for preventive care, wellness products and medication management. Europe’s mature healthcare infrastructure, strong reimbursement systems and evolving pharmacy service models continue to support stable revenue growth, while competition among pharmacy chains, independent pharmacies and online platforms shapes pricing, service quality and customer retention across the region.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Global Retail Pharmacy Market is expected to grow from USD 14,45,920.00 million in 2024 to USD 19,65,958.05 million by 2032, at a CAGR of 3.92% from 2025 to 2032.
The Europe Retail Pharmacy Market reached USD 316.70 billion in 2025 and is projected to reach USD 396.17 billion by 2032, growing at a CAGR of 3.19% from 2025 to 2032.
Prescription drugs remain the core revenue contributor, supported by chronic disease treatment demand, aging demographics, reimbursed medicine access and recurring prescription refill volumes.
Chain pharmacies lead by pharmacy type due to procurement scale, broader product portfolios, private-label expansion, standardized store formats and stronger digital integration.
Brick and mortar retail remains the dominant sales channel, driven by in-person pharmacist consultation, immediate medicine access and the trusted role of community pharmacies.
E-pharmacy, hybrid pharmacy models and digital prescription systems are reshaping competition as operators improve convenience, refill management, home delivery and customer retention.
Report Scope
This report segments the Europe Retail Pharmacy Market as follows:
Market Drivers
Rapid expansion of e-pharmacy and digital prescription ecosystems
The Europe Retail Pharmacy Market benefits from the rapid expansion of e-pharmacy platforms, digital prescription systems and omnichannel pharmacy models. Consumers increasingly prefer online ordering, home delivery and app-based prescription refills, which improve access and convenience across urban and rural areas. Digital prescription infrastructure also helps pharmacies reduce dispensing errors, manage inventory more efficiently and strengthen patient adherence programs. This shift supports higher transaction volumes, improves customer retention and allows pharmacy operators to expand beyond traditional store-based sales. It also creates long-term value for businesses by integrating prescription management, telehealth referrals and personalized wellness services into pharmacy retail operations.
Expansion of private-label and value-based pharmacy offerings
The Europe Retail Pharmacy Market continues to gain from the expansion of private-label products and value-based pharmacy offerings. Pharmacy chains increasingly promote affordable wellness, personal care, nutrition and over-the-counter products under their own brands to improve margins and strengthen customer loyalty. Consumers across Europe remain price-conscious, which supports demand for cost-effective alternatives to branded medicines and health products. Private-label portfolios also help retailers differentiate their product mix, reduce dependence on third-party brands and capture stronger profitability across high-frequency categories. This trend supports competitive positioning, especially among large pharmacy chains that use scale, procurement strength and targeted merchandising to expand value-based offerings.
Growing role of pharmacies as primary health care access points
The Europe Retail Pharmacy Market is supported by the growing role of pharmacies as accessible primary health care points. Retail pharmacies increasingly provide vaccination support, medication counseling, chronic disease management, health screening and preventive care services. This role is important in Europe because health systems face pressure from aging populations, physician shortages and rising demand for convenient care. Pharmacies help reduce the burden on clinics and hospitals by offering routine services closer to patients. This shift strengthens the strategic value of retail pharmacies, improves customer engagement and positions pharmacy operators as key partners in community-based health care delivery.
Market Trends
Expansion of digital health and omnichannel pharmacy models
The Europe Retail Pharmacy Market is seeing strong adoption of digital health tools, e-prescriptions and omnichannel pharmacy platforms. Retail pharmacy operators are combining physical stores, mobile apps, online ordering, home delivery and refill management to improve patient convenience and service continuity. This trend supports stronger customer retention because patients can manage prescriptions, wellness products and pharmacist consultations across multiple channels. It also helps pharmacies improve inventory planning, reduce waiting times and expand access in underserved areas. Digital integration is becoming a key competitive factor as consumers expect faster, more flexible and more personalized pharmacy services.
Rising adoption of private-label and value-based products
The Europe Retail Pharmacy Market is shifting toward private-label and value-based health products as consumers seek affordable options across over-the-counter medicines, personal care, nutrition and wellness categories. Pharmacy chains use private-label portfolios to improve margins, build customer loyalty and differentiate their stores from supermarkets and online retailers. This trend also supports stronger control over pricing, packaging and product positioning. Value-based offerings remain important in Europe’s cost-conscious health care environment, where consumers compare product quality, affordability and convenience before purchase. Large pharmacy networks are likely to expand these portfolios to strengthen profitability and capture repeat purchases.
Growing role of pharmacies as frontline health care hubs
The Europe Retail Pharmacy Market is evolving as pharmacies expand beyond dispensing medicines into frontline health care services. Pharmacies increasingly support vaccination programs, medication reviews, minor ailment advice, chronic disease monitoring and preventive health screening. This trend reflects the need for accessible care points as European health systems manage aging populations, higher chronic disease burdens and pressure on primary care providers. Pharmacies benefit from frequent patient interaction and trusted local presence, which allows them to support early intervention and adherence. This service-led model strengthens the role of retail pharmacies in community health care and creates new revenue opportunities beyond traditional product sales.
Market Challenges
Stringent regulatory frameworks and ownership restrictions
The Europe Retail Pharmacy Market faces challenges from strict regulatory frameworks that shape pharmacy ownership, licensing, dispensing practices and professional service standards. Several European countries maintain ownership rules that limit chain expansion or require pharmacist-led control of retail pharmacy operations. These rules protect patient safety and professional independence, but they can restrict consolidation, investment flexibility and rapid market entry. Compliance requirements also raise administrative costs for operators that manage multiple stores across different national markets. This regulatory complexity makes expansion slower and requires pharmacy businesses to adapt operating models to each country’s legal and health care system requirements.
Margin pressure from pricing controls and rising operating costs
The Europe Retail Pharmacy Market remains under pressure from medicine pricing controls, reimbursement limits and rising operating costs. Governments and payers continue to manage health care spending through regulated medicine prices, generic substitution policies and reimbursement controls. These measures support affordability for patients, but they reduce profit flexibility for pharmacies, especially in prescription drug categories. Labor costs, rent, energy expenses and digital infrastructure investments further pressure operating margins. Retail pharmacy operators must improve procurement efficiency, expand higher-margin wellness categories and strengthen private-label offerings to protect profitability in a cost-sensitive market.
Fragmented online pharmacy regulations and cross-border limitations
The Europe Retail Pharmacy Market faces barriers from fragmented online pharmacy rules and cross-border restrictions across European countries. While digital pharmacy adoption continues to grow, regulations on prescription fulfillment, remote verification, delivery, data privacy and advertising differ widely by market. These differences make it difficult for operators to scale e-pharmacy platforms across multiple countries with one standard model. Cross-border limitations also restrict access to wider customer bases and reduce the efficiency benefits of centralized digital operations. This fragmented environment slows omnichannel expansion and requires careful compliance planning for pharmacies that target regional digital growth.
Market Opportunities
Growth of E-commerce and Digital Health Solutions
The increasing demand for e-commerce and digital health solutions presents a significant opportunity for the Europe Retail Pharmacy Market. As consumer preferences shift towards online shopping for convenience, pharmacies have the chance to expand their digital presence. E-pharmacies, offering home delivery of medications, over-the-counter products, and personalized health services, are gaining traction among tech-savvy consumers. By adopting e-commerce platforms and integrating digital tools like telemedicine consultations, virtual health assessments, and mobile health apps, retail pharmacies can attract a broader customer base. This trend is particularly beneficial in reaching rural or underserved areas where access to physical pharmacies may be limited.
Moreover, the integration of artificial intelligence (AI) and machine learning into pharmacy operations offers opportunities to enhance the customer experience, such as through personalized recommendations, real-time inventory management, and automated prescriptions. The growing trend of digital health is further supported by the EU’s digital health initiatives, which encourage innovation in healthcare delivery. Retail pharmacies that embrace these digital advancements can not only cater to changing consumer preferences but also streamline operations, reduce overhead costs, and improve customer satisfaction.
Expansion into Preventive Healthcare and Wellness Products
The rising consumer interest in preventive healthcare and wellness products offers a prime opportunity for retail pharmacies in Europe. As consumers become more health-conscious and proactive about maintaining their well-being, pharmacies have the chance to diversify their product offerings beyond traditional pharmaceuticals. By expanding into the wellness segment, including vitamins, supplements, fitness aids, and organic health products, pharmacies can tap into a growing market.
Additionally, pharmacies can offer personalized wellness services, such as dietary consultations, weight management programs, and stress relief therapies, further positioning themselves as holistic health hubs. This trend aligns with the broader shift toward self-care and preventive healthcare, with consumers increasingly seeking products and services that promote long-term health and disease prevention. Retail pharmacies that capitalize on this trend can drive revenue growth while strengthening their role in overall health management, thereby enhancing customer loyalty and capturing a broader market segment.
Market Segmentation Analysis
By Product
Prescription drugs dominated the Europe Retail Pharmacy Market in 2025 with an estimated 67% share, supported by strong prescription volumes across chronic disease therapies, reimbursed medicines and long-term treatment categories. The segment benefits from Europe’s aging population, high medicine adherence needs and pharmacy-centered dispensing systems across major countries. Retail pharmacies remain key access points for regulated medicines, while electronic prescriptions and refill programs support repeat purchases. OTC products continue to grow, but prescription drugs remain the core revenue base.
By Pharmacy type
Chain pharmacies led the Europe Retail Pharmacy Market in 2025 with an estimated 42% share, driven by scale advantages, strong procurement networks, wider product availability and standardized service models. Their leadership reflects rising consolidation in several European markets and stronger investment in loyalty programs, private-label products and omnichannel platforms. Chain operators also benefit from higher brand visibility and better capacity to manage regulated pricing pressure. Independent pharmacies remain important locally, but chain pharmacies hold stronger commercial reach and operating efficiency.
By Sales channel
Brick and mortar retail dominated the Europe Retail Pharmacy Market in 2025 with an estimated 71% share, supported by consumer preference for immediate medicine access, pharmacist consultation and in-person prescription fulfillment. Physical pharmacies remain central to community health care because they provide trusted advice, urgent OTC access and regulated dispensing services. The channel also benefits from proximity-based demand in urban and rural areas. Hybrid and pure online models are expanding, but physical stores remain the primary transaction point across Europe.
By Customer type
Individual consumers dominated the Europe Retail Pharmacy Market in 2025 with an estimated 84% share, supported by daily demand for prescription medicines, OTC products, personal care items and wellness products. The segment benefits from aging demographics, rising self-care behavior and higher use of retail pharmacies for medication management and preventive health support. Individual purchasing remains frequent and broad-based across pharmacy categories. Institutional buyers contribute steady demand from clinics, hospitals and care homes, but consumer-led retail spending remains the market’s main revenue driver.
Segments
By Product
Prescription Drugs
OTC Products
By Pharmacy Type
Chain Pharmacies
Independent Pharmacies
Hospital-Attached Retail Pharmacies
Online / E-Pharmacies
Others
By Sales Channel
Brick & Mortar Retail
Hybrid (Physical + Digital)
Pure Online
By Customer Type
Individual Consumers
Institutional Buyers (Clinics, Hospitals, Care homes))
Based on Region
Western Europe
Southern Europe
Eastern Europe
Northern Europe
Central Europe
Regional Analysis
Western Europe
Western Europe holds the largest share of the Europe Retail Pharmacy Market, accounting for approximately XX% of the total market share. Key countries such as Germany, France, the UK, and the Netherlands dominate this region. These countries benefit from well-established healthcare systems, high healthcare spending, and a large consumer base with a high demand for both prescription and over-the-counter (OTC) drugs. The adoption of digital health technologies, such as e-pharmacies and online consultation services, has further accelerated market growth in this region. The growing elderly population in countries like Germany and France, combined with high rates of chronic diseases, contributes to a robust demand for pharmaceutical products and services. Western Europe also leads in regulatory advancements and healthcare innovations, making it a key region for both pharmaceutical companies and retail pharmacies.
Southern Europe
Southern Europe represents approximately XX% of the Europe Retail Pharmacy Market. Countries such as Italy, Spain, and Greece are the primary contributors to this region’s market share. The market is growing steadily due to a rising middle class, increasing health awareness, and the growing adoption of pharmacy-based health services. However, Southern European countries face challenges such as economic instability, which can affect consumer spending on non-essential medications and services. Despite this, retail pharmacies are capitalizing on the demand for preventive healthcare products, over-the-counter drugs, and personalized health services. The trend toward digital health solutions is also gaining momentum in this region, contributing to market growth.
Key players
Walgreens Boots Alliance
PHOENIX Group
Dirk Rossmann GmbH
DocMorris AG
AS Watson Group
Dr. Max Group
Day Lewis Pharmacy
Apotea AB
Redcare Pharmacy
Euro-Pharmas
Others
Competitive Analysis
The Europe Retail Pharmacy Market is competitive, with large pharmacy chains, regional operators, online pharmacy platforms and independent pharmacies competing across country-specific regulatory environments. Leading players such as Walgreens Boots Alliance, Phoenix Group, Dirk Rossmann GmbH, DocMorris AG, AS Watson, Dr. Max Group, Day Lewis Pharmacy, Apotea AB, Redcare Pharmacy and Euro-pharmas focus on store network expansion, digital pharmacy platforms, private-label products, prescription fulfillment and value-added health care services.
Competition is shaped by pricing controls, ownership restrictions, reimbursement policies and the growing shift toward omnichannel pharmacy models. Independent pharmacies continue to hold a strong position, while larger groups use procurement scale, logistics capabilities and technology integration to improve efficiency and customer retention. The market is gradually moving toward consolidation, but national regulations and strong community pharmacy networks keep the competitive landscape fragmented across Europe.
Recent Developments
In 2026, Boots launches PrescriptionsPlus to simplify managing NHS repeat prescriptions.
In January 31, 2024, Boots launched the NHS Pharmacy First service across its stores in England, marking a significant expansion in the role of community pharmacists.
In Mar 2025, HCSC announced it completed the acquisition of The Cigna Group’s Medicare businesses and CareAllies, reiterating that Cigna would continue to provide pharmacy benefit services for an agreed period post-closing.
In March 6, 2025, Walgreens Boots Alliance (WBA) entered into a definitive agreement to be acquired by the private equity firm Sycamore Partners in a transaction valued at up to $23.7 billion.
In October 15, 2025, CVS Pharmacy announced it had completed the acquisition of select assets from Rite Aid and Bartell Drugs as part of Rite Aid’s bankruptcy process.
As of March 31, 2024, Apollo Pharmacy operated 6,030 stores across approximately 1,200 cities and towns in 22 states and 5 union territories. The company continues to expand its digital healthcare platform, offering services like online medicine delivery and virtual doctor consultations.
In October 2024, Caring Pharmacy Retail Management Sdn Bhd, a 75%-owned unit of 7-Eleven Malaysia Holdings Bhd, announced acquisitions of equity interest and business assets in several pharmaceutical outlets for a combined cash consideration of RM48.86 million.
In June 2024, the Australian Competition and Consumer Commission (ACCC) expressed concerns that the proposed acquisition of Chemist Warehouse by Sigma Healthcare could substantially lessen competition in pharmacy retailing, potentially leading to higher prices and reduced service quality.
In January 2025, Watsons Philippines ended 2024 with 1,166 stores, expanding its community pharmacy format. The company opened more than 50 stores outside of Metro Manila.
Market Concentration and Characteristics
The Europe Retail Pharmacy Market shows moderate market concentration, with a mix of large pharmacy groups, regional chains, online pharmacy platforms and independent community pharmacies competing across highly regulated national markets. Leading companies such as Walgreens Boots Alliance, Phoenix Group, Dirk Rossmann GmbH, DocMorris AG, AS Watson and Dr. Max Group hold strong positions through store networks, digital platforms, procurement scale and private-label portfolios. However, independent pharmacies remain highly influential, accounting for about 62.48% of the market in 2025, which shows that the market is still fragmented despite consolidation among large operators. Market characteristics include strong dependence on prescription drug demand, rising adoption of e-pharmacy, expansion of omnichannel services, growing pharmacy-led health care services and strict country-level regulations that shape ownership, pricing and operating models. The market is also characterized by stable demand, regulated margins and increasing competition between brick-and-mortar, hybrid and pure online pharmacy formats.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The research report offers an in-depth analysis based on Product, Pharmacy Type, Sales Channel, Customer Type and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The integration of e-pharmacy platforms and digital health services will continue to grow, offering greater accessibility for consumers. Online pharmacies will play an increasingly critical role in shaping the market, driven by the demand for convenience and remote healthcare services.
Preventive healthcare products and services will experience significant growth as consumers focus more on health management. Pharmacies will expand their wellness offerings, such as dietary supplements, health screenings, and personalized health consultations.
The aging population in Europe will continue to drive the demand for chronic disease management and age-related medications. Retail pharmacies will need to adapt their services to meet the healthcare needs of the elderly, offering specialized products and care.
As chronic conditions such as diabetes, cardiovascular diseases, and respiratory issues rise, pharmacies will increasingly offer chronic disease management services. This will include medication management, health monitoring, and personalized consultations for better disease control.
The rise of telehealth and remote consultations will influence pharmacy services, allowing consumers to access healthcare advice and prescriptions digitally. Pharmacies will integrate these services to enhance customer convenience and improve healthcare access.
As the market evolves, stricter regulations regarding the sale of pharmaceuticals, e-commerce practices, and data protection will be implemented. Retail pharmacies will need to navigate these regulations to ensure compliance and minimize operational disruptions.
Retail pharmacies will diversify their product offerings to include more health and wellness products, from supplements to home healthcare devices. This diversification will help pharmacies tap into the growing self-care market and broaden their revenue streams.
Strategic partnerships, mergers, and acquisitions will increase as players seek to expand market share and enhance service offerings. Large pharmacy chains will collaborate with technology firms and healthcare providers to offer integrated health solutions.
Sustainability efforts will become increasingly important, with pharmacies focusing on reducing waste, using eco-friendly packaging, and promoting environmentally friendly products. Consumer demand for sustainable practices will drive pharmacies to implement greener solutions.
As e-pharmacies gain traction, traditional brick-and-mortar pharmacies will face intensified competition. To stay competitive, physical pharmacies will invest in digital capabilities, offering integrated services that combine both in-store and online experiences for consumers.
Table of Content
CHAPTER NO. 1 : INTRODUCTION………………………………. 27 1.1. Report Description ……………………………………………………. 27 Purpose of the Report…………………………………………..27 USP & Key Offerings……………………………………………..27 1.2. Key Benefits for Stakeholders……………………………………… 28 1.3. Target Audience ……………………………………………………….. 28
CHAPTER NO. 2 : EXECUTIVE SUMMARY……………………… 29
CHAPTER NO. 3 : RETAIL PHARMACY MAFORCES & INDUSTRY PULSE …………………………….. 31 3.1. Foundations of Change – Market Overview……………………. 31 3.2. The Rise of E-Pharmacy- Market Drive ………………………….. 34 3.2.1. Expansion of Private-Label and Value-Based Pharmacy Offerings 36 3.2.2. Growing Role of Pharmacies as Primary Healthcare Access Points and Value-Added Services…………………………………. 38 3.3. Stringent Regulatory Frameworks and Ownership Restrictions 40 3.4. Margin Pressure from Pricing Controls and Rising Operating Costs 41 3.5. Expansion of Digital Health and Omnichannel Pharmacy Models 42 3.6. Market Equilibrium – Porter’s Five Forces……………………… 43 3.7. Macro Forces – PESTEL Breakdown………………………………. 46
CHAPTER NO. 5 : VALUE CHAIN ANALYSIS- BY KEY PHARMACIES …………………………………. 50 5.1. Buying Criteria51
CHAPTER NO. 6 : COMPETITION ANALYSIS ………………….. 52 6.1. Company Market Share Analysis………………………………….. 52 6.1.1. Europe Retail Pharmacy Market Company Revenue Market Share, 2025 52 6.2. Key Strategic Developments……………………………………….. 54 6.2.1. Noted Acquisitions, Agreement, Launches in Europe Retail Pharmacy Industry ……………………………………………………. 54 6.3. Competitive Dashboard……………………………………………… 59 6.4. Company Assessment Metrics, 2025 …………………………….. 60
CHAPTER NO. 7 : EUROPE MARKET ANALYSIS, INSIGHTS & FORECAST, BY PRODUCT ………………….. 61
CHAPTER NO. 8 : EUROPE MARKET ANALYSIS, INSIGHTS & FORECAST, BY PHARMACY TYPE ………… 65
CHAPTER NO. 9 : EUROPE MARKET ANALYSIS, INSIGHTS & FORECAST, BY CUSTOMER TYPE…………. 69
CHAPTER NO. 10 : EUROPE MARKET ANALYSIS, INSIGHTS & FORECAST, BY SALES CHANNEL………….. 73
CHAPTER NO. 11 : EUROPE MARKET ANALYSIS, INSIGHTS & FORECAST, BY COUNTRY…………………… 77 11.1.1.Germany Market Analysis, Insights & Forecast, by Product.. 80 11.1.2.Germany Market Analysis, Insights & Forecast, by Pharmacy Type 81 11.1.3.Germany Market Analysis, Insights & Forecast, by Customer Type 82 11.1.4.Germany Market Analysis, Insights & Forecast, by Sales Channel 83 11.1.5.UK Market Analysis, Insights & Forecast, by Product ……….. 84 11.1.6.UK Market Analysis, Insights & Forecast, by Pharmacy Type 85 11.1.7.UK Market Analysis, Insights & Forecast, by Customer Type 86 11.1.8.UK Market Analysis, Insights & Forecast, by Sales Channel .. 87 11.1.9.France Market Analysis, Insights & Forecast, by Product…… 88 11.1.10. France Market Analysis, Insights & Forecast, by Pharmacy Type…………………………………………………………. 89 11.1.11. France Market Analysis, Insights & Forecast, by Customer Type …………………………………………………………. 90 11.1.12. France Market Analysis, Insights & Forecast, by Sales Channel 91 11.1.13. Italy Market Analysis, Insights & Forecast, by Product 92 11.1.14. Italy Market Analysis, Insights & Forecast, by Pharmacy Type…………………………………………………………. 93 11.1.15. Italy Market Analysis, Insights & Forecast, by Customer Type…………………………………………………………. 94 11.1.16. Italy Market Analysis, Insights & Forecast, by Sales Channel 95 11.1.17. Spain Market Analysis, Insights & Forecast, by Product 96 11.1.18. Spain Market Analysis, Insights & Forecast, by Pharmacy Type…………………………………………………………. 97 11.1.19. Spain Market Analysis, Insights & Forecast, by Customer Type…………………………………………………………. 98 11.1.20. Spain Market Analysis, Insights & Forecast, by Sales Channel 99 11.1.21. Belgium Market Analysis, Insights & Forecast, by Product 100 11.1.22. Belgium Market Analysis, Insights & Forecast, by Pharmacy Type…………………………………………………….101 11.1.23. Belgium Market Analysis, Insights & Forecast, by Customer Type …………………………………………………….102 11.1.24. Belgium Market Analysis, Insights & Forecast, by Sales Channel ………………………………………………………103 11.1.25. Netherlands Market Analysis, Insights & Forecast, by Product………………………………………………….104 11.1.26. Netherlands Market Analysis, Insights & Forecast, by Pharmacy Type………………………………………. 105 11.1.27. Netherlands Market Analysis, Insights & Forecast, by Customer Type………………………………………. 106 11.1.28. Netherlands Market Analysis, Insights & Forecast, by Sales Channel………………………………………… 107 11.1.29. Sweden Market Analysis, Insights & Forecast, by Product 108 11.1.30. Sweden Market Analysis, Insights & Forecast, by Pharmacy Type …………………………………………………… 109 11.1.31. Sweden Market Analysis, Insights & Forecast, by Customer Type……………………………………………………. 110 11.1.32. Sweden Market Analysis, Insights & Forecast, by Sales Channel …………………………………………………….. 111 11.1.33. Poland Market Analysis, Insights & Forecast, by Product 112 11.1.34. Poland Market Analysis, Insights & Forecast, by Pharmacy Type………………………………………………… 113 11.1.35. Poland Market Analysis, Insights & Forecast, by Customer Type ………………………………………………… 114 11.1.36. Poland Market Analysis, Insights & Forecast, by Sales Channel 115 11.1.37. Denmark Market Analysis, Insights & Forecast, by Product 116 11.1.38. Denmark Market Analysis, Insights & Forecast, by Pharmacy Type …………………………………………………… 117 11.1.39. Denmark Market Analysis, Insights & Forecast, by Customer Type …………………………………………………….118 11.1.40. Denmark Market Analysis, Insights & Forecast, by Sales Channel ………………………………………………………119 11.1.41. Switzerland Market Analysis, Insights & Forecast, by Product………………………………………………….120 11.1.42. Switzerland Market Analysis, Insights & Forecast, by Pharmacy Type ……………………………………….121 11.1.43. Switzerland Market Analysis, Insights & Forecast, by Customer Type………………………………………..122 11.1.44. Switzerland Market Analysis, Insights & Forecast, by Sales Channel………………………………………….123 11.1.45. Norway Market Analysis, Insights & Forecast, by Product 124 11.1.46. Norway Market Analysis, Insights & Forecast, by Pharmacy Type…………………………………………………….125 11.1.47. Norway Market Analysis, Insights & Forecast, by Customer Type …………………………………………………….126 11.1.48. Norway Market Analysis, Insights & Forecast, by Sales Channel ………………………………………………………127 11.1.49. Czech Republic Market Analysis, Insights & Forecast, by Product………………………………………………….128 11.1.50. Czech Republic Market Analysis, Insights & Forecast, by Pharmacy Type ……………………………………….129 11.1.51. Czech Republic Market Analysis, Insights & Forecast, by Customer Type………………………………………..130 11.1.52. Czech Republic Market Analysis, Insights & Forecast, by Sales Channel………………………………………… 131 11.1.53. Hungary Market Analysis, Insights & Forecast, by Product 132 11.1.54. Hungary Market Analysis, Insights & Forecast, by Pharmacy Type …………………………………………………… 133 11.1.55. Hungary Market Analysis, Insights & Forecast, by Customer Type……………………………………………………. 134 11.1.56. Hungary Market Analysis, Insights & Forecast, by Sales Channel …………………………………………………….. 135 11.1.57. Rest of Europe Market Analysis, Insights & Forecast, by Product………………………………………………… 136 11.1.58. Rest of Europe Market Analysis, Insights & Forecast, by Pharmacy Type………………………………………. 137 11.1.59. Rest of Europe Market Analysis, Insights & Forecast, by Customer Type………………………………………. 138 11.1.60. Rest of Europe Market Analysis, Insights & Forecast, by Sales Channel………………………………………… 139
CHAPTER NO. 12 : COMPANY PROFILE ……………………….. 140 12.1. Walgreens Boots Alliance …………………………………………. 140 12.1.1.Product Portfolio…………………………………………………….. 142 12.2. Phoenix Group ……………………………………………………….. 144 12.2.1.Product Portfolio…………………………………………………….. 147 12.3. Dirk Rossmann GmbH………………………………………………. 149 12.3.1.Product Portfolio…………………………………………………….. 151 12.4. DocMorris AG 153 12.4.1.Product Portfolio………………………………………………………155 12.5. AS Watson 157 12.5.1.Product Portfolio………………………………………………………159 12.6. Dr. Max Group161 12.6.1.Product Portfolio………………………………………………………163 12.7. Day Lewis Pharmacy………………………………………………….165 12.7.1.Product Portfolio………………………………………………………167 12.8. Apotea AB 169 12.8.1.Product Portfolio………………………………………………………171 12.9. Redcare Pharmacy (Shop Apotheke Europe) ………………….173 12.9.1.Product Portfolio………………………………………………………175 12.10. Euro-pharmas 177 12.10.1. Product Portfolio ………………………………….179
CHAPTER NO. 13 : REGULATORY FRAME WORK- RETAIL PHARMACY- EUROPE, BY COUNTRIES .. 181
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size of the Europe Retail Pharmacy Market in 2025 and 2032?
The Europe Retail Pharmacy Market is projected to grow from USD 316.70 billion in 2025 to an estimated USD 396.17 billion by 2032, with a compound annual growth rate (CAGR) of 3.19% from 2025 to 2032.
What are the key drivers of the Europe Retail Pharmacy Market’s growth?
The Europe Retail Pharmacy Market’s growth is driven by expanding e-pharmacy and digital prescription systems, rising private-label and value-based product offerings and the growing role of pharmacies as primary health care access points.
How has e-commerce influenced the Europe Retail Pharmacy Market?
E-commerce has influenced the Europe Retail Pharmacy Market by accelerating online medicine ordering, e-prescription fulfillment, home delivery and hybrid pharmacy models, while increasing price transparency, customer convenience and competition between brick-and-mortar pharmacies and digital pharmacy platforms.
Which regions contribute most to the Europe Retail Pharmacy Market?
Germany contributes the most to the Europe Retail Pharmacy Market, followed by other major country markets such as the UK, France, Italy and Spain, supported by large patient populations, strong health care infrastructure, high prescription volumes and well-established pharmacy retail networks.
Who are the key players in the Europe Retail Pharmacy Market?
The key players in the Europe Retail Pharmacy Market are Walgreens Boots Alliance, Phoenix Group, Dirk Rossmann GmbH, DocMorris AG, AS Watson, Dr. Max Group, Day Lewis Pharmacy, Apotea AB, Redcare Pharmacy (Shop Apotheke Europe) and Euro-pharmas.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.
At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.
The global OTC cough, cold, and allergy medicine market was valued at USD 23,450 million in 2024 and is projected to reach USD 32,590.02 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
Novel Cardiovascular Drug Delivery Devices Market size was valued USD 5189 million in 2024 and is anticipated to reach USD 9322.84 million by 2032, at a CAGR of 7.6% during the forecast period.
The Small Molecule Injectable market was valued at USD 141,836 million in 2024 and is anticipated to reach USD 241,884.7 million by 2032, growing at a CAGR of 6.9% during the forecast period.
Nanoparticle Formulation Market size was valued USD 8589 million in 2024 and is anticipated to reach USD 16863.73 million by 2032, at a CAGR of 8.8% during the forecast period.
Autologous Conditioned Plasma (ACP) Market size was valued USD 584 million in 2024 and is anticipated to reach USD 1366.31 million by 2032, at a CAGR of 11.2% during the forecast period.
Autogenous Vaccine Market size was valued USD 465 million in 2024 and is anticipated to reach USD 810.46 million by 2032, at a CAGR of 7.2% during the forecast period.
The global combination therapies in aesthetics market was valued at USD 3,690 million in 2024 and is projected to reach USD 6,880.69 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period.
The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.
US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.
The Reversible Airway Diseases Treatment Market size was valued at USD 85,518 million in 2024 and is anticipated to reach USD 143671.9 million by 2032, at a CAGR of 6.7 % during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
